Team:BIOTEC Dresden/Project v2

From 2009.igem.org

Revision as of 02:00, 22 October 2009 by Tomek (Talk | contribs)

Project Description

Temporal and spatial control of protein synthesis by in vitro recombination inside picoliter reactors

Manufacturing functionalized proteins in vitro poses a challenge, as it requires coordinated molecular assemblies and multi-step reactions. In this project we aim to control, over time and space, the production of proteins tagged with a silver-binding peptide for in situ silver nanoparticle nucleation inside microdroplets generated by microfluidic devices.

Combining a transcription-translation system with protein coding genes and a recombination logic inside microdroplets provides spatial control. Moreover, in the microfluidic chamber we can pinpoint the beginning of synthesis, and easily track and isolate the droplets. Site-specific recombination generates a molecular timer for temporal control of protein synthesis.

Unlike transcriptional regulation, this method gives true all-or-none induction due to covalent modification of DNA by Flp recombinase. Determining the transfer curve of inter-FRT site distance versus average recombination time allows the onset of gene expression to be predicted. We then apply this Flp reporter system as a powerful PoPS measurement device.


Realization

The project is split into three parts:

FLP Recombinase-based PoPS Measurement Device

Utilizing a new biobrick, the FLP reporter system can used to determine the transcription rate of gene expression. It can be applied to measure the persistence length of DNA by using different spacings between the FLP recombinase sites.


Gene Expression in Vesicles

Instead of gene expression in cells, it is attempted to express this system in vitro, using lipid vesicles. First of all, a method to create those vesicles is introduced, then a gene expression kit is inserted.


Biomimmetic approach to the metallization of a protein with silver In this part of the project we wanted to metallize a protein with silver. For this we used a peptide sequence known to nucleate the formation of silver nanoparticles in silver-resistant bacteria.


Retrieved from "http://2009.igem.org/Team:BIOTEC_Dresden/Project_v2"